DWM
TMO icon

Destination Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Destination Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.9M Buy
43,630
+1,241
+3% +$596K 0.51% 61
2026
Q1 		$20.8M Buy
42,389
+2,067
+5% +$1.12M 0.54% 63
2025
Q4 		$23.4M Buy
40,322
+956
+2% +$541K 0.61% 55
2025
Q3 		$19.1M Sell
39,366
-627
-2% -$292K 0.53% 62
2025
Q2 		$16.2M Buy
39,993
+2,549
+7% +$1.07M 0.48% 64
2025
Q1 		$18.6M Buy
37,444
+1,719
+5% +$931K 0.59% 63
2024
Q4 		$18.6M Buy
35,725
+361
+1% +$198K 0.58% 58
2024
Q3 		$21.9M Buy
35,364
+302
+0.9% +$179K 0.68% 59
2024
Q2 		$19.4M Buy
35,062
+350
+1% +$201K 0.64% 58
2024
Q1 		$20.2M Buy
34,712
+3,294
+10% +$1.85M 0.67% 56
2023
Q4 		$16.7M Sell
31,418
-5,607
-15% -$2.71M 0.58% 57
2023
Q3 		$18.7M Buy
37,025
+396
+1% +$211K 0.73% 51
2023
Q2 		$19.1M Buy
36,629
+78
+0.2% +$42.1K 0.71% 53
2023
Q1 		$21.1M Buy
36,551
+2,833
+8% +$1.6M 0.8% 46
2022
Q4 		$18.6M Buy
+33,718
New +$17.9M 0.74% 46
2020
Q2 		– Sell
-2,408
Closed -$683K – 164
2020
Q1 		$683K Buy
2,408
+65
+3% +$20.5K 0.04% 112
2019
Q4 		$761K Sell
2,343
-50
-2% -$15.2K 0.04% 102
2019
Q3 		$697K Buy
2,393
+139
+6% +$39.8K 0.04% 98
2019
Q2 		$662K Buy
2,254
+56
+3% +$15.4K 0.04% 105
2019
Q1 		$602K Hold
2,198
– – 0.03% 110
2018
Q4 		$492K Sell
2,198
-17
-0.8% -$3.99K 0.03% 109
2018
Q3 		$541K Buy
2,215
+17
+0.8% +$3.91K 0.03% 116
2018
Q2 		$455K Buy
2,198
+1,991
+962% +$423K 0.03% 111
2018
Q1 		$43K Buy
+207
New +$43.4K ﹤0.01% 272

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Destination Wealth Management's TMO Position: Q2 2026 in Review

Destination Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 2.9% in Q2 2026, buying an estimated $596K and bringing the position to 43,630 shares worth $21.9M. The position accounts for 0.51% of the portfolio, ranked #61.

Destination Wealth Management first reported a position in TMO in Q1 2018 and has held it in 24 quarters since. The position peaked at $23.4M in Q4 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Destination Wealth Management held 43,630 shares of Thermo Fisher Scientific worth $21.9M as of Q2 2026.
  • Destination Wealth Management bought 1,241 Thermo Fisher Scientific shares in Q2 2026, an estimated $596K.
  • Thermo Fisher Scientific made up 0.51% of Destination Wealth Management's portfolio in Q2 2026, its #61 holding.
  • Destination Wealth Management first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 24 quarters since.
  • Destination Wealth Management's Thermo Fisher Scientific position peaked at $23.4M in Q4 2025.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Destination Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.